Search for: "Purdue Pharma Inc." Results 41 - 60 of 162
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Apr 2022, 8:48 pm by Patent Docs
Gene Quinn of IPWatchdog, Inc.; Stephen Byrn of Purdue University and Improved Pharma; Steven Zeman of Grünecker Patent Attorneys and Attorneys at Law; and Eyal Barash of Barash Law, LLC will focus on questions related to obviousness and inventive step, enablement and written description sufficiency, and scientific aspects of pharmaceutical salts, and address issues related to litigation of patents directed to such salts from both a legal and expert witness point of… [read post]
13 Mar 2024, 7:17 am by Dennis Crouch
The recent case of Purdue Pharma v. [read post]
15 Jul 2014, 7:10 am by Docket Navigator
Purdue Pharma LP et al, 3-13-cv-00571 (NJD July 9, 2014, Order) (Bongiovanni, M.J.) [read post]
18 Aug 2010, 12:19 am by Kelly
and industrial applicability on 7 October: Eli Lilly & Co v Human Genome Sciences Inc (IPKat) Nuvigil (Armodafinil) – US: Cephalon and Mylan Pharmaceuticals agree to drop two patents from Nuvigil patent suit (Patent Docs) OxyContin (Oxycodone) – Patent infringement complaint filed following a Paragraph IV certification: Purdue Pharma L.P. et al. v. [read post]
10 Feb 2010, 4:47 pm
(Patent Docs) Ryzolt (Tramadol) – US: Patent infringement complaint filed following a Paragraph IV certification: Purdue Pharma Products LP et al. v. [read post]
17 Feb 2010, 8:00 am by Karen E. Keller
(patent infringement) 1/21: Purdue Pharma Products LP and Napp Pharmaceutical Group Ltd. v. [read post]
18 Nov 2009, 4:57 am
(Patent Docs) Ryzolt (Tramadol) - US: Patent infringement suit filed in response to Paragraph IV certification: Purdue Pharma Products LP et al. v. [read post]
18 Nov 2009, 4:57 am
(Patent Docs) Ryzolt (Tramadol) - US: Patent infringement suit filed in response to Paragraph IV certification: Purdue Pharma Products LP et al. v. [read post]
18 Nov 2009, 4:57 am
(Patent Docs) Ryzolt (Tramadol) - US: Patent infringement suit filed in response to Paragraph IV certification: Purdue Pharma Products LP et al. v. [read post]
22 Jul 2009, 6:05 am
(PatLit) Levaquin (Levofloxacin) – US: CAFC awards only partial costs where depositions used in multiple cases from different district courts: Ortho-McNeil Pharmaceutical, Inc. v. [read post]
28 Aug 2009, 8:11 am
(patent infringement) 9/4: Purdue Pharma Products LP, Napp Pharmaceutical Group Ltd., Ortho-McNeil-Janssen Pharmaceuticals Inc. v. [read post]
13 May 2010, 4:58 pm
Kappos (Orange Book Blog) (FDA Law Blog) OxyContin (Oxycodone) – US: Patent infringement suit following a Paragraph IV certification: Purdue Pharma L.P. et al v. [read post]
1 Apr 2020, 6:48 am by Robert Kraft
” The company “admitted to the scheme with an unnamed opioid maker, though the details of the government case closely match a public research partnership between Practice Fusion and Purdue Pharma Inc., which makes OxyContin. [read post]
12 Dec 2011, 7:24 am by Matthew Huisman
A Penalty that Includes Career Death: The former top executives and general counsel of Purdue Pharma L.P. are fighting their 12-year ban on working in the health care and pharmaceutical industries. [read post]
16 Apr 2013, 8:36 pm by Lawrence B. Ebert
Purdue Pharma Prods. [read post]